tiprankstipranks
Trending News
More News >
Osteopore Ltd. (AU:OSX)
ASX:OSX
Australian Market
Advertisement

Osteopore Ltd. (OSX) Price & Analysis

Compare
8 Followers

OSX Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.94%99.06%
Mutual Funds
― Other Institutional Investors
99.06% Public Companies and
Individual Investors

OSX FAQ

What was Osteopore Ltd.’s price range in the past 12 months?
Osteopore Ltd. lowest share price was AU$0.01 and its highest was AU$0.06 in the past 12 months.
    What is Osteopore Ltd.’s market cap?
    Osteopore Ltd.’s market cap is AU$3.11M.
      When is Osteopore Ltd.’s upcoming earnings report date?
      Osteopore Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 41 days.
        How were Osteopore Ltd.’s earnings last quarter?
        Currently, no data Available
        Is Osteopore Ltd. overvalued?
        According to Wall Street analysts Osteopore Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Osteopore Ltd. pay dividends?
          Osteopore Ltd. does not currently pay dividends.
          What is Osteopore Ltd.’s EPS estimate?
          Osteopore Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Osteopore Ltd. have?
          Osteopore Ltd. has 207,139,500 shares outstanding.
            What happened to Osteopore Ltd.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Osteopore Ltd.?
            Currently, no hedge funds are holding shares in AU:OSX

            Company Description

            Osteopore Ltd.

            Osteopore Ltd. (OSX) is a medical technology company specializing in the production and commercialization of 3D-printed bioresorbable implants. These implants are designed to support the natural stages of bone healing, providing a scaffold that gradually dissolves as the bone regenerates. The company's innovative approach targets the craniofacial, dental, and orthopedic sectors, delivering solutions that improve patient outcomes and reduce the need for revision surgeries.
            Similar Stocks
            Company
            Price & Change
            Follow
            Orthocell Ltd
            Aroa Biosurgery Ltd
            ImExHS Limited
            Emyria Ltd
            Arovella Therapeutics Limited
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis